Key points are not available for this paper at this time.
Acute myeloid leukemia(AML) is a diverse malignancy with a prognosis that varies, being especially unfavorable in older patients and those with high-risk characteristics. Metabolic reprogramming has become a significant factor in AML development , presenting new opportunities for prognostic assessment and therapeutic intervention.
Building similarity graph...
Analyzing shared references across papers
Loading...
Na Ren
Jinan University
Jianan Wang
Jiangnan University
Ruibin Li
Hebei Medical University
Frontiers in Genetics
Chinese PLA General Hospital
General Hospital of Shenyang Military Region
PLA Academy of Military Science
Building similarity graph...
Analyzing shared references across papers
Loading...
Ren et al. (Thu,) studied this question.
synapsesocial.com/papers/68e55db8e2b3180350efb4fa — DOI: https://doi.org/10.3389/fgene.2024.1424365